← Back to feedRead original →
VERIFIEDET Finance·neutral
Glenmark launches generic Olanzapine injection in US
AI Summary
- ·Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States.
- ·The injection is a treatment for schizophrenia and bipolar disorder.
- ·This launch aims to expand Glenmark's injectable offerings and institutional market presence.